The best of Nuclear Cardiology and MRI in 2003

As in previous years, the year 2003 was notable for clinical studies confirming the position occupied by Nuclear Cardiology and MRI in patient management. This was confirmed in the different areas tackled this year. In myocardial ischaemia, 2 points attracted our attention. Firstly, there is the good prognostic value of a normal myocardial perfusion (stress) CT with tetrofosmin (Myoview), which makes this good prognostic value of TEMP independent of the tracer used. Secondly, an elegant study performed in 10627 patients, once more confirming the significance of using stress TEMP in the therapeutic strategy (medical treatment versus revascularisation). Furthermore, in the area of myocardial infarction (MI), 3 points attracted our attention : the use of Annexin A5 - 99mTc was advantageous for visualising apoptosis in the territory at risk, the limits of studying regional myocardial function versus contrast MRI in the diagnosis of MI, and the good sensitivity of contrast MRI in the detection of sub-endocardial MI. In the diagnosis of acute coronary syndrome, one study reported the sensitivity and specificity of emergency MRI (84 versus 85%). In the area of myocardial viability, one study reported the inferiority of electromechanical mapping compared to TEMP and positron emission tomography. In the area of post-infarct cardiac failure, studies have confirmed the place of LVEF in the evaluation of prognosis, and combining this with BNP and possibly the study of the angiotensin converting enzyme gene. Similarly another study reported the superiority of MIBG-1231 compared to cardiac frequency variability in the evaluation of prognosis.